Detalhe da pesquisa
1.
Maintenance of hormone responsiveness in luminal breast cancers by suppression of Notch.
Proc Natl Acad Sci U S A
; 109(8): 2742-7, 2012 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-21969591
2.
Modeling luminal breast cancer heterogeneity: combination therapy to suppress a hormone receptor-negative, cytokeratin 5-positive subpopulation in luminal disease.
Breast Cancer Res
; 16(4): 418, 2014 Aug 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-25116921
3.
Luminal breast cancer metastases and tumor arousal from dormancy are promoted by direct actions of estradiol and progesterone on the malignant cells.
Breast Cancer Res
; 16(6): 489, 2014 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-25475897
4.
Malignant stroma increases luminal breast cancer cell proliferation and angiogenesis through platelet-derived growth factor signaling.
BMC Cancer
; 14: 735, 2014 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25274034
5.
Estrogen switches pure mucinous breast cancer to invasive lobular carcinoma with mucinous features.
Breast Cancer Res Treat
; 137(2): 431-48, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23247610
6.
Control of progesterone receptor transcriptional synergy by SUMOylation and deSUMOylation.
BMC Mol Biol
; 13: 10, 2012 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-22439847
7.
Unliganded progesterone receptors attenuate taxane-induced breast cancer cell death by modulating the spindle assembly checkpoint.
Breast Cancer Res Treat
; 131(1): 75-87, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21340479
8.
Cytokeratin 5 positive cells represent a steroid receptor negative and therapy resistant subpopulation in luminal breast cancers.
Breast Cancer Res Treat
; 128(1): 45-55, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20665103
9.
Rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenografts.
Proc Natl Acad Sci U S A
; 105(15): 5774-9, 2008 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18391223
10.
90 YEARS OF PROGESTERONE: Progesterone and progesterone receptors in breast cancer: past, present, future.
J Mol Endocrinol
; 65(1): T49-T63, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32485679
11.
Fibroblast subtypes define a metastatic matrisome in breast cancer.
JCI Insight
; 5(4)2020 02 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32045383
12.
GCUNC-45 is a novel regulator for the progesterone receptor/hsp90 chaperoning pathway.
Mol Cell Biol
; 26(5): 1722-30, 2006 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-16478993
13.
The Year in Basic Science: update of estrogen plus progestin therapy for menopausal hormone replacement implicating stem cells in the increased breast cancer risk.
Mol Endocrinol
; 22(12): 2743-50, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18845670
14.
Progestins in hormone replacement therapies reactivate cancer stem cells in women with preexisting breast cancers: a hypothesis.
J Clin Endocrinol Metab
; 93(9): 3295-8, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18647813
15.
Contaminating cells alter gene signatures in whole organ versus laser capture microdissected tumors: a comparison of experimental breast cancers and their lymph node metastases.
Clin Exp Metastasis
; 25(1): 81-8, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-17932773
16.
Estrogen regulated gene expression in response to neoadjuvant endocrine therapy of breast cancers: tamoxifen agonist effects dominate in the presence of an aromatase inhibitor.
Breast Cancer Res Treat
; 112(3): 489-501, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18338247
17.
Molecular signatures of neoadjuvant endocrine therapy for breast cancer: characteristics of response or intrinsic resistance.
Breast Cancer Res Treat
; 112(3): 475-88, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18327671
18.
ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive disease.
Mod Pathol
; 21(7): 912-23, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18487993
19.
Progesterone receptor action: translating studies in breast cancer models to clinical insights.
Adv Exp Med Biol
; 630: 94-111, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18637487
20.
Estrogen receptor positive breast cancer metastasis: altered hormonal sensitivity and tumor aggressiveness in lymphatic vessels and lymph nodes.
Cancer Res
; 66(18): 9308-15, 2006 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16982776